Page last updated: 2024-10-23

bretylium and Dermatitis

bretylium has been researched along with Dermatitis in 1 studies

bretylium: RN given refers to parent cpd
bretylium : A quaternary ammonium cation having 2-bromobenzyl, ethyl and two methyl groups attached to the nitrogen. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibrillation.

Dermatitis: Any inflammation of the skin.

Research Excerpts

ExcerptRelevanceReference
"The bretylium-treated animals also exhibited an improved renal pathology index but they did not differ from the controls with respect to proteinuria and hematuria."1.27Beneficial effect of captopril on systemic lupus erythematosus-like disease in MRL lpr/lpr mice. ( Herlitz, H; Svalander, C; Tarkowski, A; Volkmann, R; Westberg, G, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Herlitz, H1
Tarkowski, A1
Svalander, C1
Volkmann, R1
Westberg, G1

Other Studies

1 other study available for bretylium and Dermatitis

ArticleYear
Beneficial effect of captopril on systemic lupus erythematosus-like disease in MRL lpr/lpr mice.
    International archives of allergy and applied immunology, 1988, Volume: 85, Issue:3

    Topics: Animals; Blood Pressure; Bretylium Compounds; Captopril; Cyclophosphamide; Dermatitis; Female; Lupus

1988